Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aptevo Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aptevo Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Harsanyi Zsolt | Director | 400 | Aug 10, 2026 | 1 |
| Lamothe Jeffrey G. | President and CEO | 961 | Aug 10, 2026 | 1 |
| Taylor Daphne | SVP, CFO | 638 | Aug 10, 2026 | 1 |
| Kwon SoYoung | SVP, GC, BD & Corp Affairs | 638 | Aug 10, 2026 | 1 |
| Huebner Dirk | SVP, CMO | 482 | Aug 10, 2026 | 1 |
| Grant Grady III | Director | 1,150 | Aug 10, 2026 | 2 |
| White Marvin L | Executive Chair | 1,261 | Aug 10, 2026 | 1 |
| Abdun-Nabi Daniel | Director | 400 | Aug 10, 2026 | 1 |
| Kunz Barbara Lopez | Director | 400 | Aug 10, 2026 | 1 |
| Niederhuber John | Director | 400 | Aug 10, 2026 | 1 |
| Bank Of America Corp | 10% Owner | – | Oct 3, 2025 | 1 |
| Bank Of America NA | 10% Owner | – | Oct 3, 2025 | 1 |
| Bofa Securities, Inc. | 10% Owner | – | Oct 3, 2025 | 1 |
| El-Hibri Fuad | Director | 7,373Indirect | Dec 7, 2021 | 0 |
| Tang Kevin C | Other: Exit Filing | 0Indirect | Nov 26, 2021 | 0 |
| Tang Capital Partners LP | Other: Exit Filing | 0Indirect | Nov 26, 2021 | 0 |
| Tang Capital Management LLC | Other: Exit Filing | 0Indirect | Nov 26, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Grant Grady IIIDirector | PPurchase | +13.5K | $1.49 | +$20.1K | +1,351,300.0%13.5K after | |
| Jun 3, 2022 (view filing) | Jun 14, 2019 | 1,085 daysLate | Niederhuber JohnDirector | PPurchase | +714 | $0.91 | +$649.74 | +89.0%1.52K after | |
| Nov 26, 2021 (view filing)1:02 PM ET | Nov 23 | 3 days | Tang Kevin C and 2 othersOther: Exit Filing | SSale | −921.3K | $11.25 | −$10.4M | −100.0%0 after | 7 lots |
| Nov 22, 2021 (view filing)5:26 PM ET | Nov 18-22 | 4 days | Tang Kevin C and 2 others10% Owner | SSale | −838.7K | $7.75 | −$6.50M | −47.7%921.3K after | 10 lots |